Podcast by Author(s): Leandro B. Bergantin Jun 17, 2020

Journal Name: Anti-Cancer Agents in Medicinal Chemistry

Abstract: Limitations on the pharmacotherapy and a high prevalence worldwide are critical issues related to depression and cancer. It has been discussed that a dysregulation of intracellular Ca2+ homeostasis is involved in the pathogenesis of both these diseases. In addition, depression raises the risk of cancer incidence. Consistent data support the concept that depression is an independent risk issue for cancer. However, the cellular mechanisms involved in this link between depression and cancer remain uncertain. Considering our previous reports about Ca2+ and cAMP signalling pathways (Ca2+/cAMP signalling), I herein discussed the putative contribution of Ca2+/cAMP signalling in this link between depression and cancer. Moreover, it is important to take depression into account during the process of prevention and treatment of cancer. Read out the full article here: https://www.eurekaselect.com/179571/article

Subscribe to our YouTube channel for more: https://bit.ly/2Uq4Cm9